Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03335761 · ClinicalTrials.gov registry record · NA
InterStim® Amplitude Study
A NA study, sponsored by MedtronicNeuro.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
NCT03335761 is a NA study that has completed, run by MedtronicNeuro. The registered enrollment target is 97 participants.
The verdict
NCT03335761, a NA study, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
Study Summary
This feasibility study will explore the effects of three different InterStim amplitude settings on overactive bladder symptoms (OAB).
Interventions
- DEVICE InterStim Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2018-02-27 |
| Est. Completion | 2019-11-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03335761
The ClinicalTrials.gov registry entry for NCT03335761 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which InterStim Therapy is the first listed.
NCT03335761 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03335761 about?
NCT03335761 is a clinical study titled "InterStim® Amplitude Study". This feasibility study will explore the effects of three different InterStim amplitude settings on overactive bladder symptoms (OAB).
What is the current status of trial NCT03335761?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2018-02-27. Estimated completion is 2019-11-06.
What interventions are being tested in trial NCT03335761?
The interventions under investigation include: InterStim Therapy (DEVICE).
Who is sponsoring clinical trial NCT03335761?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.